GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Sale Of Investment

SEEGENE (XKRX:096530) Sale Of Investment : ₩700,709 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Sale Of Investment?

SEEGENE's sale of investment for the three months ended in Mar. 2024 was ₩102,035 Mil. It means SEEGENE gained ₩102,035 Mil from selling investments. SEEGENE's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩700,709 Mil.

Compared with last quarter (₩326,792 Mil in Dec. 2023 ), SEEGENE gained less money from selling investments in Mar. 2024 (₩102,035 Mil).


SEEGENE Sale Of Investment Historical Data

The historical data trend for SEEGENE's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Sale Of Investment Chart

SEEGENE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,140.22 7,005.98 11,957.73 31,532.68 609,332.47

SEEGENE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,659.01 67,104.79 204,776.85 326,791.83 102,035.47

SEEGENE Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩700,709 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SEEGENE Sale Of Investment Related Terms

Thank you for viewing the detailed overview of SEEGENE's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


SEEGENE (XKRX:096530) Business Description

Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE (XKRX:096530) Headlines

No Headlines